Indicative Borrow Rate Increases Among Liquid Names: RXRX, POET, USAR, and More
ByAinvest
Saturday, Aug 16, 2025 12:36 am ET1min read
GRRR--
The latest data from TipRanks shows that these increases reflect a growing interest and confidence in these companies' financial prospects. The borrow rate is an indicator of a stock's liquidity and the demand for short selling, which can be influenced by various factors such as market sentiment, earnings reports, and strategic developments.
Recursion Pharmaceuticals, for instance, has been leveraging AI to improve the development of new therapeutics, which could be a key driver behind its increased borrow rate. The company's focus on biological data and AI integration has positioned it as a leader in innovative drug development [1].
For investors, these borrow rate increases can serve as a signal of market sentiment and potential future performance. However, it is crucial to conduct thorough analysis and consider other financial metrics before making investment decisions.
References:
[1] https://www.forbes.com/video/eeacdb51-4fd5-404a-95bb-ad3fb1727938/how-ai-is-fixing-the-90-drug-failure-rate/
[2] https://www.tipranks.com/news/the-fly/largest-borrow-rate-increases-among-liquid-names-thefly-57
KGC--
NSC--
OMER--
POET--
Liquid option names such as Recursion Pharmaceuticals (RXRX), Poet Technologies (POET), and USA Rare Earth Inc (USAR) have seen significant increases in indicative borrow rates, with RXRX experiencing a 41.81% increase. Other stocks with notable increases include Norfolk Southern (NSC), Gorilla Technology Group Inc (GRRR), Kinross Gold (KGC), and Omeros (OMER).
In recent market developments, several liquid option names have experienced significant increases in indicative borrow rates. Among the most notable are Recursion Pharmaceuticals (RXRX), Poet Technologies (POET), and USA Rare Earth Inc (USAR), with RXRX seeing a substantial 41.81% increase [2]. Other stocks with significant borrow rate increases include Norfolk Southern (NSC), Gorilla Technology Group Inc (GRRR), Kinross Gold (KGC), and Omeros (OMER).The latest data from TipRanks shows that these increases reflect a growing interest and confidence in these companies' financial prospects. The borrow rate is an indicator of a stock's liquidity and the demand for short selling, which can be influenced by various factors such as market sentiment, earnings reports, and strategic developments.
Recursion Pharmaceuticals, for instance, has been leveraging AI to improve the development of new therapeutics, which could be a key driver behind its increased borrow rate. The company's focus on biological data and AI integration has positioned it as a leader in innovative drug development [1].
For investors, these borrow rate increases can serve as a signal of market sentiment and potential future performance. However, it is crucial to conduct thorough analysis and consider other financial metrics before making investment decisions.
References:
[1] https://www.forbes.com/video/eeacdb51-4fd5-404a-95bb-ad3fb1727938/how-ai-is-fixing-the-90-drug-failure-rate/
[2] https://www.tipranks.com/news/the-fly/largest-borrow-rate-increases-among-liquid-names-thefly-57

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet